Compugen gains after taking small step toward large market (CGEN)

Posted in General 
June 23rd, 2009

Compugen Ltd (CGEN) shares are up more than 25% on strong early volume after the small company announced positive therapeutic effects of a novel peptide in an animal model of treating inflammatory bowel disease.

The company said that in a recently completed study of TNBS-induced colitis, the administration of CGEN-25007 protected mice from the effects of lethal colitis. Study data showed an increase in survival rate and reversal of weight loss.

 

Comments are closed

-->